IP 20

Known as: IP-20, Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ala-His-Asp, peptide inhibitor IP-20 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
LH increases the intracellular Ca(2+) concentration ([Ca(2+)](i)) in mice Leydig cells, in a process triggered by calcium influx… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
The effects of PGE(2) on longitudinal smooth muscle, the intracellular mechanisms involved, and the localization of EP receptors… (More)
Is this relevant?
2000
2000
The potent cannabinoid receptor agonist WIN 55,212-2 produces positive shifts in steady-state inactivation of the potassium A… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1996
1996
Certain eukaryotic cells can sense changes in their extracellular Ca2+ concentration through molecular structures termed Ca(2… (More)
Is this relevant?
1992
1992
Interleukin-1/3 (IL-1/3) induces a dose-dependent increase in the release of corticotropin-releasing factor-41 (CRF) from… (More)
Is this relevant?
1992
1992
Interleukin-1 beta (IL-1 beta) induces a dose-dependent increase in the release of corticotropin-releasing factor-41 (CRF) from… (More)
Is this relevant?
1992
1992
5-Hydroxytryptamine (5-HT) has been shown to activate the hypothalamo-pituitary-adrenal axis, possibly by a direct action on… (More)
Is this relevant?
1989
1989
In contrast with previous reports, it was found that membrane-protein phosphorylation by the catalytic subunit (CS) of cyclic AMP… (More)
Is this relevant?